nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.156	0.356	CbGbCtD
Bismuth Subsalicylate—PTGS2—Etoposide—peripheral nervous system neoplasm	0.153	0.349	CbGbCtD
Bismuth Subsalicylate—PTGS1—Etoposide—peripheral nervous system neoplasm	0.129	0.295	CbGbCtD
Bismuth Subsalicylate—TF—pons—peripheral nervous system neoplasm	0.0126	0.425	CbGeAlD
Bismuth Subsalicylate—TF—Differentiation Pathway—ALK—peripheral nervous system neoplasm	0.0084	0.173	CbGpPWpGaD
Bismuth Subsalicylate—TF—ganglion—peripheral nervous system neoplasm	0.00647	0.218	CbGeAlD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00409	0.0841	CbGpPWpGaD
Bismuth Subsalicylate—TF—trigeminal ganglion—peripheral nervous system neoplasm	0.00318	0.107	CbGeAlD
Bismuth Subsalicylate—TF—brainstem—peripheral nervous system neoplasm	0.00281	0.0947	CbGeAlD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.00218	0.0448	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—HGF—peripheral nervous system neoplasm	0.00215	0.0443	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—ganglion—peripheral nervous system neoplasm	0.00192	0.0646	CbGeAlD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.00172	0.0354	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.00172	0.0353	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.00164	0.0337	CbGpPWpGaD
Bismuth Subsalicylate—Asthma—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00337	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.00163	0.00337	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.00163	0.00337	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.00161	0.00334	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Epirubicin—peripheral nervous system neoplasm	0.0016	0.00332	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Tretinoin—peripheral nervous system neoplasm	0.0016	0.00332	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Isotretinoin—peripheral nervous system neoplasm	0.0016	0.00332	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00156	0.00323	CcSEcCtD
Bismuth Subsalicylate—Burning sensation—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00313	CcSEcCtD
Bismuth Subsalicylate—Erythema—Tretinoin—peripheral nervous system neoplasm	0.0015	0.0031	CcSEcCtD
Bismuth Subsalicylate—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.0031	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00307	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Alitretinoin—peripheral nervous system neoplasm	0.00148	0.00307	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00301	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.00143	0.0294	CbGpPWpGaD
Bismuth Subsalicylate—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.0014	0.00291	CcSEcCtD
Bismuth Subsalicylate—Stinging—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0029	CcSEcCtD
Bismuth Subsalicylate—TF—cerebellum—peripheral nervous system neoplasm	0.00139	0.0467	CbGeAlD
Bismuth Subsalicylate—Epistaxis—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00283	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.00136	0.028	CbGpPWpGaD
Bismuth Subsalicylate—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00133	0.00275	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00133	0.00275	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.0027	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.0013	0.00269	CcSEcCtD
Bismuth Subsalicylate—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.00268	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00268	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00125	0.00259	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00255	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00123	0.00255	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00123	0.00255	CcSEcCtD
Bismuth Subsalicylate—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00122	0.00253	CcSEcCtD
Bismuth Subsalicylate—Infection—Topotecan—peripheral nervous system neoplasm	0.00122	0.00253	CcSEcCtD
Bismuth Subsalicylate—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00122	0.00253	CcSEcCtD
Bismuth Subsalicylate—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00122	0.00253	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00252	CcSEcCtD
Bismuth Subsalicylate—Infection—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00251	CcSEcCtD
Bismuth Subsalicylate—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00251	CcSEcCtD
Bismuth Subsalicylate—Oedema—Melphalan—peripheral nervous system neoplasm	0.00121	0.0025	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.00249	CcSEcCtD
Bismuth Subsalicylate—Infection—Melphalan—peripheral nervous system neoplasm	0.0012	0.00248	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00118	0.0242	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00117	0.00243	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00241	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00241	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00115	0.00238	CcSEcCtD
Bismuth Subsalicylate—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00235	CcSEcCtD
Bismuth Subsalicylate—TF—EPHB forward signaling—NRAS—peripheral nervous system neoplasm	0.00112	0.0229	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00225	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00225	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00224	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00108	0.00224	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00108	0.0222	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00107	0.00223	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00107	0.00223	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00107	0.00222	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.0022	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00106	0.0022	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00106	0.0022	CcSEcCtD
Bismuth Subsalicylate—Constipation—Topotecan—peripheral nervous system neoplasm	0.00105	0.00218	CcSEcCtD
Bismuth Subsalicylate—Pain—Topotecan—peripheral nervous system neoplasm	0.00105	0.00218	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00105	0.00217	CcSEcCtD
Bismuth Subsalicylate—Pain—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00216	CcSEcCtD
Bismuth Subsalicylate—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00216	CcSEcCtD
Bismuth Subsalicylate—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00216	CcSEcCtD
Bismuth Subsalicylate—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00216	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00215	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00214	CcSEcCtD
Bismuth Subsalicylate—Pain—Melphalan—peripheral nervous system neoplasm	0.00103	0.00213	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00213	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00101	0.0021	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00208	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00208	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00208	CcSEcCtD
Bismuth Subsalicylate—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000998	0.00207	CcSEcCtD
Bismuth Subsalicylate—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000992	0.00205	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000978	0.00203	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000974	0.02	CbGpPWpGaD
Bismuth Subsalicylate—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000973	0.00202	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00097	0.00201	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00097	0.00201	CcSEcCtD
Bismuth Subsalicylate—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000966	0.002	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000965	0.002	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000965	0.002	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000961	0.00199	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Doxorubicin—peripheral nervous system neoplasm	0.00096	0.00199	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000958	0.00198	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.000956	0.00198	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000951	0.00197	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.000949	0.00197	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000933	0.00193	CcSEcCtD
Bismuth Subsalicylate—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000925	0.00192	CcSEcCtD
Bismuth Subsalicylate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000919	0.0019	CcSEcCtD
Bismuth Subsalicylate—PTGS2—trigeminal ganglion—peripheral nervous system neoplasm	0.0009	0.0303	CbGeAlD
Bismuth Subsalicylate—Oedema—Vincristine—peripheral nervous system neoplasm	0.000892	0.00185	CcSEcCtD
Bismuth Subsalicylate—Infection—Vincristine—peripheral nervous system neoplasm	0.000886	0.00183	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000885	0.00183	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000882	0.00183	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000879	0.0181	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000871	0.0018	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000868	0.0018	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000867	0.0018	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000864	0.00179	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000864	0.00179	CcSEcCtD
Bismuth Subsalicylate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000854	0.00177	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000853	0.00177	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00085	0.00176	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000842	0.00174	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000841	0.00174	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000835	0.00173	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000835	0.00173	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000827	0.00171	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000825	0.00171	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000823	0.0017	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000822	0.0017	CcSEcCtD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000817	0.0168	CbGpPWpGaD
Bismuth Subsalicylate—TF—EPHB forward signaling—HRAS—peripheral nervous system neoplasm	0.000816	0.0168	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000815	0.00169	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000814	0.00169	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000807	0.00167	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000807	0.00167	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000804	0.00167	CcSEcCtD
Bismuth Subsalicylate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000791	0.00164	CcSEcCtD
Bismuth Subsalicylate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000791	0.00164	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000789	0.00163	CcSEcCtD
Bismuth Subsalicylate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000789	0.00163	CcSEcCtD
Bismuth Subsalicylate—Infection—Cisplatin—peripheral nervous system neoplasm	0.000783	0.00162	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000783	0.00162	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000778	0.00161	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000776	0.00161	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000776	0.00161	CcSEcCtD
Bismuth Subsalicylate—Rash—Topotecan—peripheral nervous system neoplasm	0.000776	0.00161	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000775	0.00161	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000775	0.00161	CcSEcCtD
Bismuth Subsalicylate—Headache—Topotecan—peripheral nervous system neoplasm	0.000771	0.0016	CcSEcCtD
Bismuth Subsalicylate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00077	0.00159	CcSEcCtD
Bismuth Subsalicylate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00077	0.00159	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000769	0.00159	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000769	0.00159	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000766	0.00159	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000765	0.00159	CcSEcCtD
Bismuth Subsalicylate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000765	0.00158	CcSEcCtD
Bismuth Subsalicylate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000765	0.00158	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000763	0.00158	CcSEcCtD
Bismuth Subsalicylate—Pain—Vincristine—peripheral nervous system neoplasm	0.000763	0.00158	CcSEcCtD
Bismuth Subsalicylate—Constipation—Vincristine—peripheral nervous system neoplasm	0.000763	0.00158	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000762	0.0157	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Melphalan—peripheral nervous system neoplasm	0.00076	0.00157	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000759	0.00157	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000752	0.00156	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000752	0.00156	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000735	0.00152	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000732	0.00152	CcSEcCtD
Bismuth Subsalicylate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000731	0.00151	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000728	0.00151	CcSEcCtD
Bismuth Subsalicylate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000725	0.0015	CcSEcCtD
Bismuth Subsalicylate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000725	0.0015	CcSEcCtD
Bismuth Subsalicylate—Infection—Etoposide—peripheral nervous system neoplasm	0.000718	0.00149	CcSEcCtD
Bismuth Subsalicylate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000716	0.00148	CcSEcCtD
Bismuth Subsalicylate—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000712	0.00147	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000705	0.00146	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000698	0.0144	CbGpPWpGaD
Bismuth Subsalicylate—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000696	0.00144	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000689	0.00143	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000685	0.00142	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000683	0.00141	CcSEcCtD
Bismuth Subsalicylate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000674	0.0014	CcSEcCtD
Bismuth Subsalicylate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.00136	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.00136	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00065	0.00135	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000648	0.00134	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000642	0.00133	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000635	0.00132	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000635	0.0131	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000635	0.00131	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000633	0.00131	CcSEcCtD
Bismuth Subsalicylate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000629	0.0013	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000628	0.0013	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000623	0.00129	CcSEcCtD
Bismuth Subsalicylate—Pain—Etoposide—peripheral nervous system neoplasm	0.000618	0.00128	CcSEcCtD
Bismuth Subsalicylate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000618	0.00128	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000612	0.00127	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00061	0.00126	CcSEcCtD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.000602	0.0124	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.0006	0.00124	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000599	0.00124	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000595	0.00123	CcSEcCtD
Bismuth Subsalicylate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000593	0.00123	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00059	0.00122	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000588	0.00122	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000587	0.00122	CcSEcCtD
Bismuth Subsalicylate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000583	0.00121	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000583	0.00121	CcSEcCtD
Bismuth Subsalicylate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00058	0.0012	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000574	0.00119	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000571	0.00118	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00057	0.00118	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000567	0.00117	CcSEcCtD
Bismuth Subsalicylate—Rash—Vincristine—peripheral nervous system neoplasm	0.000562	0.00116	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000562	0.00116	CcSEcCtD
Bismuth Subsalicylate—Headache—Vincristine—peripheral nervous system neoplasm	0.000559	0.00116	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.00115	CcSEcCtD
Bismuth Subsalicylate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00114	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00054	0.00112	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000539	0.00112	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000531	0.0011	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vincristine—peripheral nervous system neoplasm	0.00053	0.0011	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.00109	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000511	0.00106	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000501	0.00104	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000499	0.00103	CcSEcCtD
Bismuth Subsalicylate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000497	0.00103	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000497	0.00103	CcSEcCtD
Bismuth Subsalicylate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000496	0.00103	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000494	0.00102	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.00102	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000486	0.00101	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000478	0.000989	CcSEcCtD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	0.000473	0.00973	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000468	0.00097	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000459	0.000951	CcSEcCtD
Bismuth Subsalicylate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000951	CcSEcCtD
Bismuth Subsalicylate—Rash—Etoposide—peripheral nervous system neoplasm	0.000455	0.000943	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000455	0.000943	CcSEcCtD
Bismuth Subsalicylate—Headache—Etoposide—peripheral nervous system neoplasm	0.000453	0.000937	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00045	0.000931	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000439	0.00903	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000429	0.000889	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000424	0.00872	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000412	0.00847	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000846	CcSEcCtD
Bismuth Subsalicylate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000839	CcSEcCtD
Bismuth Subsalicylate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000833	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.000393	0.00809	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000393	0.00808	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—cerebellum—peripheral nervous system neoplasm	0.000393	0.0132	CbGeAlD
Bismuth Subsalicylate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000799	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000782	CcSEcCtD
Bismuth Subsalicylate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000776	CcSEcCtD
Bismuth Subsalicylate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000771	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00037	0.0076	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000746	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.00074	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000738	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000729	CcSEcCtD
Bismuth Subsalicylate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000717	CcSEcCtD
Bismuth Subsalicylate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000717	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000344	0.00707	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000691	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.00069	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000683	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—HGF—peripheral nervous system neoplasm	0.000327	0.00673	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000675	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000666	CcSEcCtD
Bismuth Subsalicylate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000664	CcSEcCtD
Bismuth Subsalicylate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000664	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000663	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000313	0.00644	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000312	0.00642	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000639	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000298	0.00613	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000616	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000297	0.00612	CbGpPWpGaD
Bismuth Subsalicylate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000613	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000292	0.006	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000593	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000574	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000555	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000549	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000261	0.00536	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000533	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000531	CcSEcCtD
Bismuth Subsalicylate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000529	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000528	CcSEcCtD
Bismuth Subsalicylate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000525	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000248	0.00511	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000248	0.0051	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000513	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.000247	0.00509	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.000246	0.00505	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000498	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000239	0.00491	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000493	CcSEcCtD
Bismuth Subsalicylate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000489	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000489	CcSEcCtD
Bismuth Subsalicylate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000486	CcSEcCtD
Bismuth Subsalicylate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000461	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.00022	0.00453	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.00021	0.00431	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000206	0.00424	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000205	0.00422	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000202	0.00415	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000201	0.00413	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000187	0.00384	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000184	0.00378	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.00018	0.0037	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000168	0.00346	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000165	0.0034	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000163	0.00336	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000161	0.00331	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000144	0.00295	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000139	0.00286	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000139	0.00286	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000136	0.0028	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000133	0.00273	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000132	0.00272	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000127	0.00262	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000127	0.00261	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000124	0.00254	CbGpPWpGaD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000119	0.00245	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000116	0.00238	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000116	0.00238	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00011	0.00227	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—peripheral nervous system neoplasm	0.00011	0.00226	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000105	0.00216	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000102	0.0021	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	0.000101	0.00207	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	9.95e-05	0.00205	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	9.65e-05	0.00199	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	9.64e-05	0.00198	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GNS—peripheral nervous system neoplasm	9.53e-05	0.00196	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	9.28e-05	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—AKT1—peripheral nervous system neoplasm	9.27e-05	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.26e-05	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.18e-05	0.00189	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.93e-05	0.00184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.41e-05	0.00173	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	7.98e-05	0.00164	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	7.92e-05	0.00163	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	7.72e-05	0.00159	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	7.65e-05	0.00157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.42e-05	0.00153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	7.37e-05	0.00152	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	7.16e-05	0.00147	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.73e-05	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	6.67e-05	0.00137	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.56e-05	0.00135	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GNS—peripheral nervous system neoplasm	6.46e-05	0.00133	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	6.26e-05	0.00129	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NME1—peripheral nervous system neoplasm	6.19e-05	0.00127	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	6.09e-05	0.00125	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	5.96e-05	0.00123	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—COX2—peripheral nervous system neoplasm	5.96e-05	0.00123	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	5.77e-05	0.00119	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.42e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.39e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.32e-05	0.00109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	5.15e-05	0.00106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.91e-05	0.00101	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	4.84e-05	0.000996	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	4.84e-05	0.000995	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	4.65e-05	0.000958	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.55e-05	0.000936	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.35e-05	0.000895	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	4.09e-05	0.000841	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	3.95e-05	0.000813	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	3.91e-05	0.000805	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.9e-05	0.000802	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.88e-05	0.000798	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	3.84e-05	0.00079	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	3.31e-05	0.00068	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.28e-05	0.000674	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.15e-05	0.000649	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	3.14e-05	0.000645	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TH—peripheral nervous system neoplasm	3.11e-05	0.000639	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.08e-05	0.000633	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	2.62e-05	0.000538	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	2.6e-05	0.000535	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	2.54e-05	0.000522	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	2.49e-05	0.000512	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	2.06e-05	0.000423	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	2e-05	0.000412	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.91e-05	0.000394	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.69e-05	0.000348	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	1.56e-05	0.000322	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MYC—peripheral nervous system neoplasm	1.46e-05	0.0003	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	1.14e-05	0.000236	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000219	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000208	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	8.47e-06	0.000174	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	6.85e-06	0.000141	CbGpPWpGaD
